Close Menu

NEW YORK – MDxHealth reported Wednesday that its revenues for the first half of 2020 fell 9 percent year over year, as product revenues also saw a 9 percent decline over the prior-year period.

For the six months ended June 30, total revenues fell to $9.9 million from $10.9 million in H1 2019. Product revenues fell to $9.6 million from $10.6 million in the prior-year period. Revenues from royalties, patents, and other income fell 6 percent to $284,000 from $302,000.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.